207221 - An observational, retrospective cohort database study to assess the safety of Boostrix (U.S. formulation), a reduced tetanus, diphtheria, acellular pertussis vaccine (Tdap), following routine immunization of pregnant women in the United States.

08/03/2018
16/04/2024
EU PAS number:
EUPAS22912
Study
Finalised
Documents
Study protocol
Initial protocol
English (984.11 KB - PDF) View document
Updated protocol
English (1.45 MB - PDF) View document
Study results
Study results
English (5.59 MB - PDF) View document
Study report
Other information